Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 79 pages

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) development landscape ...

February 2018 54 pages

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) development landscape Develop ...

February 2018 90 pages

Hypoparathyroidism: Drug Development Pipeline Study, H1 2018

US$ 806.00

... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...

February 2018 32 pages

Impetigo: Drug Development Pipeline Study, H1 2018

US$ 806.00

... the Impetigo industry. Excerpts from- “Impetigo- Drug Development Pipeline Study”: Impetigo pipeline comprises of 4 drugs under development as of February 2018. Of these, 2 drugs are in Phase 2 and 1 drug is in phase 2/3. Further, 1 drug is in Pre-Clinical Stage. No drugs have ...

February 2018 22 pages

Pontine Glioma (DIPG):Drug Development Pipeline Study, H1 2018

US$ 806.00

... Diffuse Intrinsic Pontine Glioma (DIPG) industry. Excerpts from- “Diffuse Intrinsic Pontine Glioma (DIPG)- Drug Development Pipeline Study”: Pontine Glioma pipeline comprises of 24 drugs under development as of February 2018. Of these, 6 drugs are in Phase 1 and 3 drugs are in phase ...

February 2018 65 pages

North America Over the Counter Drugs Market - Forecasts from 2018 to 2023

US$ 3,200.00

... help the clients in gaining faster and efficient understanding of the North America over the counter drugs market. Major industry players profiled as part of the ... , Pfizer Inc., and Bayer AG others. Segmentation The North America over the counter drugs market has been analyzed through following segments: By ...

February 2018 78 pages

Vaccine Contract Manufacturing Market Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit, Toxoid, DNA), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), And Segment Forecasts, 2018 - 2025

US$ 5,950.00

The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by ...

February 2018 144 pages

Global Drug Eluting Implants Market - Forecasts from 2018 to 2023

US$ 3,600.00

... among others. Segmentation The Global Drug Eluting Implants market has been analyzed through following segments: By Type Biodegradable Drug Eluting Implants Non-Biodegradable Drug Eluting Implants By Application Cardiology Oncology Diabetes ...

February 2018 81 pages

Global OTC Drugs Market 2018-2024

US$ 2,750.00

Global Over the Counter Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Over-the-counter medications, also known as non-prescription drugs ... are more than 300,000 OTC drug product are marketed. Some of the common applications of OTC drugs are aches, pains, itches ...

February 2018 83 pages

2018 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Hobby, toy, & game stores-Product & Retail Report

US$ 199.00

The 2018 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Hobby, toy, & game stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Hobby, toy, & game stores nationally and for all 50 U.S. States and up to 900 ...

February 2018 76 pages

Global Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Botox market. Chapter 1, to describe Botox Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Botox, with sales ...

February 2018 108 pages

ASIA PACIFIC BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

US$ 1,250.00

KEY FINDINGS The Asia-Pacific botanical and plant derivative drug market is predicted ... as compared to traditional methods. Indian botanical and plant derivative drug market is expected to exhibit ... the adoption of botanical and plant derivative drugs by the governments of other Asia-Pacific countries like Japan ...

February 2018 87 pages

EUROPE BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

US$ 1,250.00

KEY FINDINGS The Europe botanical and plant derivative drug market is predicted to be worth $10 billion by the end of 2026. ... . The various types of botanical and plant derivative drugs include glycosides, steroids, terpenes, and phenols. In order to develop botanical drugs in Europe, the manufacturer has to ...

February 2018 90 pages

NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

US$ 1,250.00

... North America botanical and plant derivative drug market is predicted to expand at a CAGR of 7.57%, for the forecast period of 2018-2026. MARKET INSIGHTS Several noted vendors in North America ... are increasingly promoting the deployment of botanical drugs and products as ...

February 2018 92 pages

Global Biopharmaceutical Market Report & Forecast (2018-2023)

US$ 1,999.00

... and Restraining the Global Biopharmaceutical Market Key Aspects Analyzed: Driving Factors Restraining Factors Market Opportunities Threats Comprehensive Situation Analysis of the Global Biopharmaceutical Market and its ...

February 2018 210 pages

GLOBAL BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026

US$ 2,500.00

KEY FINDINGS The Global Botanical and plant-derivative drug market was estimated to be worth $ 26621 million in 2017. Due to ... a worth of $53850 million by its end. MARKET INSIGHTS The global botanical and plant-derivative drug market is segmented on the basis of types, products and therapeutic ...

February 2018 160 pages

Pharmaceutical Packaging Market Report: Trends, Forecast and Competitive Analysis

US$ 4,850.00

... to pharmaceutical packaging. Some of the features of “Pharmaceutical Packaging Market Report: Trends, Forecast and Competitive Analysis” include: Market size estimates: Global pharmaceutical packaging market size estimation in terms of value ($M) shipment.Trend and forecast analysis: Market trend (2012 ...

February 2018 188 pages

Cognitive and Memory Enhancer Drugs Market

US$ 5,370.00

... concentration. The global cognitive and memory enhancer drugs market was valued ... cognitive and memory enhancer drugs market is driven by surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory ...

February 2018 185 pages

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

US$ 2,400.00

... analysis of 10 cancer tubulin inhibitors commercially available in the market. “Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024” Report highlights: Clinical Insight on 70 Tubulin Inhibitors in pipeline Dosage & Price Analysis of 10 Commercialized Drugs Patent ...

February 2018 225 pages

Needle-Free Drug Injection Systems: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems in US$ Million. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2018 183 pages

Acute Myeloid Leukaemia:KOL Insight

US$ 8,495.00

... they expect developers to differentiate their pipeline therapies in KOL Insight: Acute Myeloid Leukaemia. Twelve US and European KOLs give their insight on six marketed products and 13 pipeline programmes ...

January 2018 -

Galectin 1 (14 kDa Laminin Binding Protein or 14 kDa Lectin or Beta Galactoside Binding Lectin L 14 I or Galaptin or HBL or HPL or Lactose Binding Lectin 1 or Lectin Galactoside Binding Soluble 1 or Putative MAPK Activating Protein PM12 or S Lac Lectin 1 or LGALS1) - Pipeline Review, H1 2018

US$ 3,500.00

... Galectin 1 (14 kDa Laminin Binding Protein or 14 kDa Lectin or Beta Galactoside Binding Lectin L 14 I or Galaptin or HBL or HPL or Lactose Binding Lectin 1 or Lectin Galactoside Binding Soluble 1 or Putative MAPK Activating Protein PM12 or S Lac Lectin 1 or LGALS1) targeted therapeutics under development ...

January 2018 62 pages

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) development landscape Develop and design ...

January 2018 39 pages

78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) - Pipeline Review, H1 2018

US$ 3,500.00

... Furthermore, this report also reviews key players involved in 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) targeted therapeutics development with respective active and dormant ...

January 2018 37 pages

Breakthrough Therapy (BT) Designation Market Analysis Report By Application (Oncology, Infectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases, Neurological Disorders), And Segment Forecasts, 2015 - 2025

US$ 5,950.00

The global breakthrough therapy designation market is anticipated to reach USD 144.6 billion by 2025, according to a new report by Grand View Research, Inc. Breakthrough Therapy (BT) designation is granted to drugs that display ...

January 2018 131 pages

Alcohol Testing And Drug Testing Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2019 to 2025

US$ 4,400.00

... significant growth as law enforcement and companies test for substance abuse. Alcohol abuse and drug abuse represent a significant danger to society. ... businesses and law enforcement agencies crack down on abuse of alcohol and drugs. WinterGreen Research is an independent research organization funded by the ...

January 2018 348 pages

North America Loratadine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... to deeply display the North America Loratadine market. Chapter 1, to describe Loratadine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

January 2018 120 pages

North America Human Fibrinogen Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... North America Human Fibrinogen market. Chapter 1, to describe Human Fibrinogen Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Human Fibrinogen ...

January 2018 115 pages

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2018

US$ 3,500.00

... Toll Like Receptor 4 (hToll or CD284 or TLR4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 126 pages

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) targeted therapeutics development with respective ...

January 2018 55 pages

2018-2022 Animal Health: Market Segment Forecasts, and Leading Supplier Strategies, Marketing Tactics, and Technological Know-How

US$ 4,850.00

... report presents a worldwide strategic overview of the animal health market, including Five-year forecasts for: Major market segments Key geographic regions Assessment of major U.S. and ...

January 2018 110 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Urokinase Market 2017 Forecast to 2022

US$ 4,880.00

... report focuses on the Urokinase in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Pharmaceutical Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

January 2018 124 pages

United States Flu Vaccine Market by Manufacturers, States, Type and Application, Forecast to 2022

US$ 4,480.00

... the United States Flu Vaccine market. Chapter 1, to describe Flu Vaccine Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Flu Vaccine ...

January 2018 122 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cell Sorting Market 2017 Forecast to 2022

US$ 4,880.00

... This report focuses on the Cell Sorting in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... LLC Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia ...

January 2018 122 pages

North America Pharmaceutical Autoclaves Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... to deeply display the North America Pharmaceutical Autoclaves market. Chapter 1, to describe Pharmaceutical Autoclaves Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

January 2018 120 pages

Fibromyalgia - Pipeline Review, H1 2018

US$ 2,000.00

... . The Fibromyalgia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fibromyalgia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2018 68 pages

Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H1 2018

US$ 3,500.00

... being developed by Companies/Universities. It also reviews key players involved in Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) targeted therapeutics development with ...

January 2018 96 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018

US$ 3,500.00

... Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 83 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2018

US$ 3,500.00

... Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 75 pages

P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2018

US$ 3,500.00

... P2X Purinoceptor 3 (P2RX3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 53 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2018

US$ 3,500.00

... Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 55 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2018

US$ 3,500.00

... P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 34 pages

72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) development landscape Develop ...

January 2018 33 pages

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Pipeline Review, H1 2018

US$ 3,500.00

... Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 53 pages

Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) development landscape Develop and design in-licensing and ...

January 2018 39 pages

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2018

US$ 3,500.00

... Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 41 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2018

US$ 3,500.00

... Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 74 pages

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) development landscape Develop and ...

January 2018 65 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2018

US$ 3,500.00

... Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 44 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1